Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-24-018278

Options or other derivatives

  • CHF CORP DEVEL OFF, GEN COUNS acquired 170,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS 2024-06-24 Grant or award · Stock Option (Right to Buy) +170,000 170,000 D
Loading xslF345X05/form4-06272024_010654.xml…